What's New

What's New

in Foods

November 4, 2011: Health Canada has a new approach to regulating energy drinks as foods instead of as NHP's. View Health Canada's press release

The Vancouver Sun's take on the situation: Health Canada struggles to regulate food product health claims

August 4, 2011: Canada's new food allergen labelling regulations will come into force on this day. Food allergies, celiac disease and sulphite sensitivity affect approximately 1.75 million Canadians. To see the new regulations visit Project 1220 Enhanced Labelling for Food Allergen and Gluten Sources and Added Sulphites

in Natural Health Products

August 29th- October 28, 2011 is the time period that you can comment on the following proposed changes. The NHPD has produced a paper outlining proposed changes to the site licensing/ product licence application process entitled Risk-Based Approach to Site Licensing (RBASL) Concept Paper. With the proposed changes, manufacturers, packagers and labellers would be required to have an on-site audit demonstrating compliance with the GMP standards prior to the issuance, renewal or amendment of a site licence.

You can submit your comments by email or fax:

Email: nhpd-dpsn.activ@hc-sc.gc.ca
Fax: 613-948-6810

in Cosmetics
March 2011 Changes to the Cosmetic Ingredient Hotlist : Items added

Acrylamide monomer (79-06-1). This ingredient has been added as a prohibition due to health concerns and to reflect its proposed addition to Schedule 1 of the CEPA 1999, as assessed through the Government of Canada's Chemicals Management Plan.

Aluminum chloride (7446-70-0; 7784-13-6). This ingredient has been added as a restriction to reflect a change in the classification of antiperspirant products as per the Products at the Cosmetic-Drug Interface (PCDI) Product Assessment Against Criteria: Antiperspirants.

Aluminum chlorohydrate (12042-91-0) and its associated complexes. These ingredients have been added as a restriction to reflect a change in the classification of antiperspirant products as per the Products at the Cosmetic-Drug Interface (PCDI) Product Assessment Against Criteria: Antiperspirants.

Aluminum zirconium complexes. These ingredients have been added as a restriction to reflect a change in the classification of antiperspirant products as per the Products at the Cosmetic-Drug Interface (PCDI) Product Assessment Against Criteria: Antiperspirants.

Benzyl chloride (100-44-7). This ingredient has been added as a prohibition due to health concerns and to reflect its proposed addition to Schedule 1 of the CEPA 1999, as assessed through the Government of Canada's Chemicals Management Plan.

4,4'-Bis(dimethylamino)benzophenone (Michler's ketone) (90-94-8). This ingredient has been added as a prohibition due to health concerns and to reflect its proposed addition to Schedule 1 of the CEPA 1999, as assessed through the Government of Canada's Chemicals Management Plan.

1,3-Butadiene (106-99-0). This ingredient has been added as a prohibition due to health concerns and to reflect its proposed addition to Schedule 1 of the CEPA 1999, as assessed through the Government of Canada's Chemicals Management Plan.

Butane (106-97-8). This ingredient has been added as a restriction due to concerns with 1,3-butadiene impurities.

CI 12120 (pigment red 3) (2425-85-6). This ingredient has been added as a prohibition due to health concerns and to reflect its proposed addition to Schedule 1 of the CEPA 1999, as assessed through the Government of Canada's Chemicals Management Plan.

Diethyl sulfate (64-67-5). This ingredient has been added as a prohibition due to health concerns and to reflect its proposed addition to Schedule 1 of the CEPA 1999, as assessed through the Government of Canada's Chemicals Management Plan.

Dimethyl sulfate (77-78-1). This ingredient has been added as a prohibition due to health concerns and to reflect its proposed addition to Schedule 1 of the CEPA 1999, as assessed through the Government of Canada's Chemicals Management Plan.

Isobutane (75-28-5). This ingredient has been added as a restriction due to concerns with 1,3-butadiene impurities.

Methoxydiglycol (diethylene glycol monomethyl ether) (111-77-3). This ingredient has been added as a prohibition due to health concerns and to reflect its proposed addition to Schedule 1 of the CEPA 1999, as assessed through the Government of Canada's Chemicals Management Plan.

Methoxyethanol acetate (110-49-6). This ingredient has been added as a prohibition due to health concerns and to reflect its proposed addition to Schedule 1 of the CEPA 1999, as assessed through the Government of Canada's Chemicals Management Plan.

Methoxyisopropanol (propylene glycol monomethyl ether) (107-98-2). This ingredient has been added as a prohibition due to health concerns, as assessed by the Government of Canada's Chemicals Management Plan (CMP) under CEPA 1999.

Methoxyisopropyl acetate (propylene glycol monomethyl ether acetate) (108-65-6; 84540-57-8). The ingredient has been added as a prohibition due to health concerns, as assessed by the Government of Canada's Chemicals Management Plan (CMP) under CEPA 1999.

2-Methoxypropanol (1589-47-5). This ingredient has been added as a prohibition due to health concerns and to reflect its proposed addition to Schedule 1 of the CEPA 1999, as assessed through the Government of Canada's Chemicals Management Plan.

2-Methoxypropyl-1-acetate (70657-70-4). This ingredient has been added as a prohibition due to health concerns, as assessed by the Government of Canada's Chemicals Management Plan (CMP) under CEPA 1999.